Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Birth Control Guidance For Insurers Aims To Boost Coverage, Smooth Exemption ‘Pathway’

Executive Summary

Three-agency guidance, issued as Biden administration is hoping to emphasize reproductive rights in its reelection campaign, outlines the narrow set of circumstances in which a health plan doesn’t have to fully cover certain types of birth control.

You may also be interested in...



‘D’ Is for Dynamic: CMS Proposals Could Shake Up Medicare Drug Benefits

While many IRA changes are seen as having an adverse effect on stand-alone PDPs, tweaks to the risk adjustment model, TrOOP calculation, and enhanced plan benefit designs rolled out by CMS make predicting how the market will shake out difficult.

The Next Big PBM Deal? Rumored Cigna-Humana Talks Raise Overlap Question

Vigorous regulatory scrutiny is a given, but opinions vary about how much the companies’ respective PBM businesses present a major antitrust risk.

Banning Spread Pricing on PBMs Alone May Have Little Impact, Study Suggests

As legislation moves forward in Congress, an examination of high-utilization Part D-covered generic drugs concludes that other payers in the supply chain make almost as much money from spread pricing as PBMs do.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS149818

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel